Navigation Links
Upsher-Smith Announces Commercial Availability Of Morphine Sulfate ER Capsules
Date:8/29/2013

MAPLE GROVE, Minn., Aug. 29, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., today announced its Morphine Sulfate Extended-Release Capsules, CII will be commercially available on September 4, 2013.

(Logo:  http://photos.prnewswire.com/prnh/20130520/NY17281LOGO )

Historically, there have been a limited number of morphine sulfate generics available.  Upsher-Smith used its extensive formulation experience to overcome the challenges presented.

Upsher-Smith's family of Morphine Sulfate Extended-Release Capsules, CII includes seven dosage strengths: 10 mg, 20 mg, 30 mg, 50 mg, 60 mg, 80 mg, and 100 mg.  This will be the first generic entrant for the 10-mg extended-release capsule dosage strength.1 Upsher-Smith's generic drug segment is dedicated to providing high-quality pharmaceutical products that are affordable and accessible to patients.

About Upsher-Smith
Upsher-Smith is an independent specialty pharmaceutical company dedicated to its mission of Advancing Pharmacotherapy to Improve Life™. Upsher-Smith currently leverages its core strength in formulation development to drive both branded and generic therapeutic solutions to address patients' needs ranging in scope from women's health to cardiology. The Company has a particular focus on developing therapies for people living with challenging central nervous system conditions like epilepsy, and has an emerging neurology pipeline with three products in clinical development.  For more information, visit www.upsher-smith.com.

Please see Full Prescribing Information, including Boxed Warning, at http://www.upsher-smith.com/wp-content/uploads/MorphineSulfate_MI.pdf.

References
1. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. http://www.accessdata.fda.gov/scripts/cder/ob/docs/tempai.cfm.  Accessed May 9, 2013.


'/>"/>
SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Upsher-Smith Teams Up With Epilepsy Foundation Of Minnesota For 2013 Stroll For Epilepsy
2. Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261 (Intranasal Midazolam) For Rescue Treatment Of Seizure Clusters In Epilepsy
3. Upsher-Smith Is Honored With Prestigious Industry Award For Leadership And Innovation
4. Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures
5. Upsher-Smith Introduces Newly Redesigned Corporate Website
6. Upsher-Smith Presents Data Supporting Favorable Tolerability And Consistent Pharmacokinetic Profile Of Once-Daily USL255 (Extended-Release Topiramate)
7. Emerging Data From Upsher-Smiths CNS Portfolio Highlighted At 2013 American Academy Of Neurology Meeting
8. Doug Zitnak of Upsher-Smith Laboratories Named Small Brand Manufacturer Representative of the Year By Cardinal Health
9. Tina Fehr, Senior Product Manager For AmLactin, Upsher-Smith Laboratories Named PM360 Trailblazer Winner For Womens Health Brand Manager
10. Upsher-Smith Teams Up With Epilepsy Foundation of Minnesota for 2012 Stroll for Epilepsy
11. Upsher-Smith Is Honored with Prestigious Industry Award for Excellence and Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 /PRNewswire/ ... Diabetes Tomorrow,s Leaders Scholarship is any indication, the future ... today online at www.diabetesscholars.org by the Diabetes ... stand in the way of academic and community service ... scholarship program since 2012, and continues to advocate for ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Cut Pro X users can now reveal the media of their split screens ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest ... . , Millions of individuals in the United States and Canada wear eyeglasses. Once ... to both correct vision and make a fashion statement. Even celebrities use glasses as ...
(Date:6/26/2016)... ... , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center ... Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This annual ... the world’s leading providers of cereal and other breakfast foods. Its residents often refer ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
Breaking Medicine News(10 mins):